155 related articles for article (PubMed ID: 4720890)
1. 6-Aminodopamine-induced degeneration of catecholamine neurons.
Jonsson G; Sachs C
J Neurochem; 1973 Jul; 21(1):117-24. PubMed ID: 4720890
[No Abstract] [Full Text] [Related]
2. Actions of 6-hydroxydopamine quinones on catecholamine neurons.
Jonsson G; Sachs C
J Neurochem; 1975 Oct; 25(4):509-16. PubMed ID: 1173817
[No Abstract] [Full Text] [Related]
3. Development of the blood-brain barrier for 6-hydroxydopamine.
Sachs C
J Neurochem; 1973 Jun; 20(6):1753-60. PubMed ID: 4719317
[No Abstract] [Full Text] [Related]
4. Changes in central noradrenaline neurons after systemic 6-hydroxydopamine administration.
Sachs C; Jonsson G
J Neurochem; 1973 Dec; 21(6):1517-24. PubMed ID: 4771442
[No Abstract] [Full Text] [Related]
5. Degeneration of adrenergic nerves produced by 6-hydroxydopamine.
Malmfors T; Sachs C
Eur J Pharmacol; 1968 Apr; 3(1):89-92. PubMed ID: 5654676
[No Abstract] [Full Text] [Related]
6. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
Sachs C; Jonsson G
Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
[No Abstract] [Full Text] [Related]
7. Failure of 6-hydroxynoradrenaline to produce degeneration of catecholamine neurons.
Sachs C
Eur J Pharmacol; 1972 Nov; 20(2):149-55. PubMed ID: 4651204
[No Abstract] [Full Text] [Related]
8. Effects of drugs on the 6-hydroxydopamine induced degeneration of adrenergic nerves.
Jonsson G; Malmfors T; Sachs C
Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):543-56. PubMed ID: 5034513
[No Abstract] [Full Text] [Related]
9. Effect of tyrosine hydroxylase inhibition on the action of 6-hydroxydopamine.
Jonsson G; Sachs C
Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):287-96. PubMed ID: 4144667
[No Abstract] [Full Text] [Related]
10. In vitro studies on central and peripheral monoamine neurons at the ultrastructural level.
Hökfelt T
Z Zellforsch Mikrosk Anat; 1968; 91(1):1-74. PubMed ID: 5724812
[No Abstract] [Full Text] [Related]
11. Degeneration of central and peripheral noradrenaline neurons produced by 6-hydroxy-DOPA.
Sachs C; Jonsson G
J Neurochem; 1972 Jun; 19(6):1561-75. PubMed ID: 5035304
[No Abstract] [Full Text] [Related]
12. 6-Hydroxydopamine induced degeneration of noradrenaline neurons in the scorbutic guinea-pig.
Jonsson G; Lohmander S; Sachs C
Biochem Pharmacol; 1974 Sep; 23(18):2585-93. PubMed ID: 4153539
[No Abstract] [Full Text] [Related]
13. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of amine uptake in tubero-infundibular dopamine neurones and in catecholamine cell bodies of the area postrema.
Fuxe K; Hamberger B; Malmfores T
J Pharm Pharmacol; 1966 Aug; 18(8):543-4. PubMed ID: 4381861
[No Abstract] [Full Text] [Related]
15. The biochemical and pharmacological properties of 6-aminodopamine: similarity with 6-hydroxydopamine.
Heikkila RE; Mytilineou C; Côté LJ; Cohen G
J Neurochem; 1973 Jul; 21(1):111-6. PubMed ID: 4720889
[No Abstract] [Full Text] [Related]
16. Animal models for an enzymic blood-brain barrier mechanism for therapeutically administered L-dopa.
Dowson JH
Life Sci; 1973 Jul; 13(1):23-9. PubMed ID: 4753023
[No Abstract] [Full Text] [Related]
17. Noradrenaline nerve terminals in the cerebral cortex: effects on noradrenaline uptake and storage following axonal lesion with 6-hydroxydopamine.
Lidbrink P; Jonsson G
J Neurochem; 1974 May; 22(5):617-26. PubMed ID: 4152079
[No Abstract] [Full Text] [Related]
18. Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of brain.
Constantinidis J; Bartholini G; Tissot R; Pletscher A
Experientia; 1968 Feb; 24(2):130-1. PubMed ID: 5643797
[No Abstract] [Full Text] [Related]
19. Degeneration and regrowth of adrenergic nerve fibers in the rat peripheral tissues after 6-hydroxydopamine.
de Champlain J
Can J Physiol Pharmacol; 1971 Apr; 49(4):345-55. PubMed ID: 5124933
[No Abstract] [Full Text] [Related]
20. Uptake and accumulation of 3 H-6-hydroxydopamine in adrenergic nerves.
Jonsson G; Sachs C
Eur J Pharmacol; 1971 Sep; 16(1):55-62. PubMed ID: 5157530
[No Abstract] [Full Text] [Related]
[Next] [New Search]
